Related references
Note: Only part of the references are listed.Prognostic significance of additional chromosomal abnormalities at the time of diagnosis in patients with chronic myeloid leukemia treated with frontline tyrosine kinase inhibitors
Ahmad Alhuraiji et al.
AMERICAN JOURNAL OF HEMATOLOGY (2018)
Mutational profiling of acute lymphoblastic leukemia with testicular relapse
Ling-Wen Ding et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2017)
The BCR-ABL1 transcript type influences response and outcome in Philadelphia chromosome-positive chronic myeloid leukemia patients treated frontline with imatinib
Fausto Castagnetti et al.
AMERICAN JOURNAL OF HEMATOLOGY (2017)
Poor outcomes associated with+1der(22) t(9;22) and-9/9p in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia receiving chemotherapy plus a tyrosine kinase inhibitor
Nicholas J. Short et al.
AMERICAN JOURNAL OF HEMATOLOGY (2017)
Mutational landscape, clonal evolution patterns, and role of RAS mutations in relapsed acute lymphoblastic leukemia
Koichi Oshima et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Molecular-defined clonal evolution in patients with chronic myeloid leukemia independent of the BCR-ABL status
M. Schmidt et al.
LEUKEMIA (2014)
BCR-ABL1 compound mutations in tyrosine kinase inhibitor-resistant CML: frequency and clonal relationships
Jamshid S. Khorashad et al.
BLOOD (2013)
Molecular characterization of de novo Philadelphia chromosome-positive acute myeloid leukemia
Sergej Konoplev et al.
LEUKEMIA & LYMPHOMA (2013)
Additional chromosomal abnormalities in Philadelphia-positive clone: adverse prognostic influence on frontline imatinib therapy: a GIMEMA Working Party on CML analysis
Simona Luatti et al.
BLOOD (2012)
Fluorescence in situ hybridization patterns of BCR/ABL1 fusion in chronic myelogenous leukemia at diagnosis
Jain P. Poonam et al.
INDIAN JOURNAL OF PATHOLOGY AND MICROBIOLOGY (2012)
A Comparative Analysis of Molecular Genetic and Conventional Cytogenetic Detection of Diagnostically Important Translocations in More Than 400 Cases of Acute Leukemia, Highlighting the Frequency of False-Negative Conventional Cytogenetics
Rebecca L. King et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2011)
Impact of additional cytogenetic aberrations at diagnosis on prognosis of CML: long-term observation of 1151 patients from the randomized CML Study IV
Alice Fabarius et al.
BLOOD (2011)
Impact of additional chromosomal aberrations and BCR-ABL kinase domain mutations on the response to nilotinib in Philadelphia chromosome-positive chronic myeloid leukemia
Theo D. Kim et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2010)
Philadelphia-positive patients who already harbor imatinib-resistant Bcr-Abl kinase domain mutations have a higher likelihood of developing additional mutations associated with resistance to second- or third-line tyrosine kinase inhibitors
Simona Soverini et al.
BLOOD (2009)
Gain-of-function mutation of GATA-2 in acute myeloid transformation of chronic myeloid leukemia
Su-Jiang Zhang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
JAK/STAT, Raf/MEK/ERK, PI3K/Akt and BCR-ABL in cell cycle progression and leukemogenesis
LS Steelman et al.
LEUKEMIA (2004)
Detection of BCR-ABL mutations in patients with CML treated with imatinib is virtually always accompanied by clinical resistance, and mutations in the ATP phosphate-binding loop (P-loop) are associated with a poor prognosis
S Branford et al.
BLOOD (2003)
Patterns of BCR/ABL gene rearrangements by interphase fluorescence in situ hybridization (FISH) in BCR/ABL+ leukemias:: incidence and underlying genetic abnormalities
D Primo et al.
LEUKEMIA (2003)
Jak2 is involved in c-Myc induction by Bcr-Abl
SH Xie et al.
ONCOGENE (2002)
The impact of clonal evolution on response to imatinib mesylate (ST1571) in accelerated phase CML
ME O'Dwyer et al.
BLOOD (2002)
Primitive, quiescent, Philadelphia-positive stem cells from patients with chronic myeloid leukemia are insensitive to STI571 in vitro
SM Graham et al.
BLOOD (2002)
Alterations of P53 and RB genes and the evolution of the accelerated phase of chronic myeloid leukemia
Z Beck et al.
LEUKEMIA & LYMPHOMA (2000)
Share Paper
